Smarter Analyst
Premium Services
  • Home
  • Analyst Insights
    • All Sectors
    • Biotech Stocks
    • Technology Stocks
    • Consumer Stocks
    • Industrial Stocks
    • Financial Stocks
    • Facebook (FB) Storms Into the Blockchain Space; Top Analyst Weighs in on the Stock

      Jon Hadad Jon Hadad, February 15, 2019
    • Top Analyst Remains Bullish on CenturyLink (CTL) Stock Despite Dividend Cut

      Jon Hadad Jon Hadad, February 15, 2019
    • Opportunities for Apple (AAPL) to Lift Stock Through Acquisitions, J.P. Morgan Says

      Jon Hadad Jon Hadad, February 14, 2019
  • Stock News
    • All Sectors
    • Biotech Stocks
    • Technology stocks
    • Consumer Stocks
    • Industrial Stocks
    • Financial Stocks
    • Top Analyst Remains Bullish on CenturyLink (CTL) Stock Despite Dividend Cut

      Jon Hadad Jon Hadad, February 15, 2019
    • After Moving the Goalposts Twice, NVIDIA (NVDA) Finally Scores; Stock Soars 7%

      S.A. Team S.A. Team, February 14, 2019
    • Teva Stock Slips on Back of Weak 2019 Outlook; Analysts Weigh In

      Jason Cohen Jason Cohen, February 13, 2019
  • Hedge-Fund Moves
    • Billionaire Steve Cohen Dumps Advanced Micro Devices (AMD) Stock, Pulls the Trigger on Qualcomm (QCOM)

      Jon Hadad Jon Hadad, January 2, 2019
    • Billionaire Steven Cohen Flips the Script: Picking Up Facebook (FB) Stock, Tuning Out Roku (ROKU)

      Shanna Fuld Shanna Fuld, December 31, 2018
    • Billionaire Izzy Englander Throws Chunk of Amarin (AMRN) Stock Out to Sea, But Reels in Bausch Health (BHC)

      Shanna Fuld Shanna Fuld, December 27, 2018
  • Cannabis-Stock Buzz
    • Cronos (CRON) Stock Looks Chronically Overpriced

      S.A. Team S.A. Team, February 14, 2019
    • Aurora Cannabis’ (ACB) Investment in High Tide Pays Off

      Corey Williams, February 13, 2019
    • Aurora Cannabis (ACB) Completes First Commercial Export of Cannabis Oil to the UK

      Corey Williams, February 11, 2019
  • Bloggers Corner
    • Electronic Arts (EA): Wall Street Is Wrong About Apex Legends

      Loup Ventures Loup Ventures, February 15, 2019
    • NVIDIA (NVDA) Stock: Prepare for Range-Bound Trading Ahead

      Loup Ventures Loup Ventures, February 15, 2019
    • A Glimpse Into Nvidia (NVDA) Stock Before the Earnings Curtain Rises

      Daily Wealth Daily Wealth, February 12, 2019
  • Investment newsletters
    • The Daily Insider
    • Bio Portfolio
    • The Big Short
    • Small-Cap Rockets
    • Go Sector
    • Guru Portfolio

Catabasis


Celsion Corporation (CLSN) Wins Over Maxim’s Bullish Blessing, Catabasis Pharmaceuticals Inc (CATB) Has Cowen Encouraged After Promising Pivotal DMD Phase II Trial Results

Celsion strikes iron while its hot to raise $15.6 million; Catabasis slows rate of DMD decline in OLE trial.

Julie Lamb Julie Lamb — October 5, 2017, 9:55 AM EDT

Find MoreRelated Articles

Wedbush Shares Two Cents On Catabasis Pharmaceuticals (CATB) Following Clinical Results In DMD

Rebecca Assaraf, Editor, April 25, 2017
Biotech StocksLong IdeasMost Popular

H.C. Wainwright Slashes Catabasis Pharmaceuticals Inc (CATB) Price Target in Half, But Sticks with Buy Rating

Julie Lamb, March 20, 2017
Biotech StocksLong IdeasMost Popular

Catabasis Pharmaceuticals Inc (CATB) Is in Rollercoaster Mode

Julie Lamb, March 13, 2017
Biotech StocksLong Ideas
Banner

Banner

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts

Thank You For Signing Up
Error Signing Up. Please Try Again.
Follow us on Facebook Follow us on twitter Follow us on StockTwits
Privacy Policy | rss feedRSS feeds | Submit Tips | About Us | Contact Us Copyright © 2019 Smarter Analyst - All Rights Reserved